Analyses of public databases demonstrated that higher expressions of EGFR, LGR5, and IL-6 in CRC patients were associated with a significantly lower survival ratio and coincided with lower expression of miR-142-3p, a suppressor of these oncogenic markers. The gene discussed is IL6; the disease is colorectal carcinoma.